1/40
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced | Call with Kai | Chat |
|---|
No analytics yet
Send a link to your students to track their progress
what does vit D help with?
absorption of Ca and P
dose for vitamin D adult supplement
600-800 IU
what form of vit D is synthesized in the skin through sun exposure?
deficient after winter
fatty fish, eggs
cholecalciferol
vit D _____________ dementia, but does not ____________ it
prevents, reverse
list the order of vitamin D synthesis
7 dehydrocholesterol
previtamin D
cholecalciferol
calcidiol
calcitriol
what type of vitamin D is used for supplements because of better potency, bioavailability, and duration?
calciferol D3
what type of vit D is given with liver disease?
calcidiol
what type of vit D is given with kidney pts?
calcitriol
what is usually LOW in RLS pts?
iron w
what should RLS pts avoid?
alcohol
obstructive sleep apnea
antihistamines
serotogenic
antidopamine meds
what are the three first line medications for RLS? what should also be given?
gabapentin enacarbil
gabapentin
pregabalin
iron supplements!
second line for RLS
ER oxy
perineal nerve stimulation
dipyridamole
what should you NOT give RLS pts?
dopamine agonists
what is low in PD pts?
dopamine
PD pts have problems in the __________ ________ of the brain
substantia nigra
what do you initially prescribe early PD pts?
IR levodopa, lowest dose
what are the two types of surgeries for PD pts?
deep brain stimulation
high focus ultrasound
vitamin D
MOA: converted to active form by kidneys and liver, boost Ca absorption
Use: vit D deficiency
Dose: 50,000 IU a day for 8 weeks → 1500-2000 afterward
SE: constipation, appetite loss, hypervitaminosis, polyuria, Ca nephrolithiasis
warning: fat soluble = potential toxicity, monitor levels :)
gabapentin enacarbil
renally adjusted
somnolence, dizziness
gabapentin
enhances gaba
used for seizures, RLS
renally adjusted
dizziness, ataxia
pregabalin
gaba analog
used for partial seizures, RLS
renal dosing
carbidopa levadopa
MOA: carb makes sure to LEAVE levo in the brain
dose: adjustment due to “wearing off”
SE: levadopa induced dyskinesias (LID), nausea, vomiting, vivid dreams, hallucinations, ICDs
drug rxns: MAO-I, linezolid (HTN → adjust with phenytoin, metoclopramide, antihypertensive
notes: take 1-2 hrs after protein for proper ab, it does wear off
delayed on
time for PD drug to take effect
peak dose dyskinesias
too much PD drug, physical effects
wearing off
re-emergence of PD symptoms after drug decreases
on-off
PD disease fluctuating symptoms
what do you give a pt for LID?
amantidine
dopamine agonists
MOA: stimulate dopamine
use: younger pts to delay levadopa use
types: promiprexole, ropinorole, rotigotine, apomorphine
SE: dizzy, sleep (NO DRIVING!!!), ICDs
hat does apomorphine do?
fixes a PD “freeze”
MAO-B inhibitors
MOA: limits dopamine breakdown
use: younger pts to avoid levodopa, or advanced pts to increase on time
types: rasagiline, safanimide (ADD ON ONLY)
SE: gambling behaviors
drug rxns: tyramine, serotonin syndrome, dont use with MAO-I
COMT inhibitor
MOA: block enzyme that breaks down levodopa
use: extends levadopa use, MUST be an add on
types: entacaprone, stalevo, opicaprone, tolcapone
SE: dyskinesia
Amantidine
MOA: helps with dopamine
Use: LID, mild early PD (not the best)
dose: start low and titrate
SE: peripheral edema, GT prolong
hallmark of alzheimers
amyloid beta plaques
decreased acetylcholine
low stimulation of NMDA receptors
amyloid PET/CT used for diagnosis, CSF testing helps too
B amyloid and Tau CSF biomarkers are abnormal
how do you treat moderate to severe alzheimers?
symptomatic treatment
donepezil
memantine
if you have moderate to severe alzheimers, what are you NOT eligible for?
disease modifying therapy —> monoclonal antibodies
scale used to stage dementia
clinical dementia rating
at what clinical dementia ratings are pts eligible for monoclonal antibodies?
if its over 2, they are NOT a candidate
0.5, 1
anti-amyloid monoclonal antibodies
MOA: target amyloid B and promote clearance via phagocytosis
Types: lecanemab (AB protofibrils), donanemab (AB epitopes, establish plaques)
use: MCI with confirmed B amyloid plaques
dose: lecanemab (SQ maintenence), donanemab (treat to clear)
SE: amyloid related imaging abnormalities (edema/effucion/microhemorrhage) → ARIA symptoms: HA, dizzy, confusion
contraindications: anticoagulants, higher ARIA rates, MRI exclusions, moderate to severe AD
acetylcholinesterase inhibitors
MOA: decreases AChE
use: mild-moderate AD
dose/type: donepezil
SE: diarrhea, nausea, vomiting
drug reactions: anticholinergics, ramelteon
monitor: symptoms, GI bleed
notes: take at bedtime
NMDA receptor agonist
MOA: NMDA agonist
use: moderate to severe AD
dose/type: memantine
SE: HTN, hypotension, dizzy, HA
drug reactions: urinary alkalizers
notes: memantine and donezapil can be taken together
for AD, what type of meds are first line? second line?
first line = acetylcholinesterase
second line = NMDA receptor agonist